{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:09:52Z","timestamp":1791500992977,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"345 Talent Project of Shengjing Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>We evaluated the epidemiology, clinical characteristics, microbiology, outcomes, and risk factors for mortality of candidemia in adult surgical patients in Shenyang from 2012 to 2018.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We designed a retrospective observational study of adult patients with candidemia in a teaching hospital including three hospital campuses. Data regarding clinical and demographic characteristics were collected from the patient\u2019s medical records.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Of the 236 cases of candidemia, 172 (72.9%) were identified in surgical patients, including 146 (84.9%) general surgeries, 11 (6.4%) urologic surgeries, 6 (3.5%) thoracic surgeries, and others. Higher proportions of solid tumors, total parenteral nutrition, the presence of a urinary catheter, and the presence of a gastric tube were observed in surgical patients with candidemia versus non-surgical ones, whereas the percentages of hematological malignancy, diabetes mellitus, and renal replacement therapy were relatively lower in surgical patients. Renal failure, leukopenia, and thrombocytopenia were less common laboratory findings in surgical patients with candidemia than compared to non-surgical ones. Among surgical patients with candidemia, <jats:italic>Candida parapsilosis<\/jats:italic> was the predominant species (43%), followed by <jats:italic>C. albicans<\/jats:italic> (33.7%), <jats:italic>C. glabrata<\/jats:italic> (11%), <jats:italic>C. tropicalis<\/jats:italic> (8.1%), and others (4.1%). Overall susceptibility, susceptible dose dependent or intermediate susceptibility, and resistance to fluconazole were detected in 73.3, 19.8, and 3.5% <jats:italic>Candida<\/jats:italic> isolates from surgical patients, respectively, but no resistance to amphotericin B was observed. Overall, the 30-day mortality in surgical patients was 19.2%. At multivariable analysis, independent risk factors for death in surgical patients with candidemia were ICU stay, thrombocytopenia, and <jats:italic>C. albicans<\/jats:italic> infection.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Surgical patients account for the majority of candidemia cases. Among patients with recent surgery, risk factors for species distribution, antifungal sensitivity patterns of <jats:italic>Candida<\/jats:italic> isolates causing candidemia, and independent risk factors for mortality should be evaluated and considered for a better outcome in the antifungal treatment.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12879-020-05238-6","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T12:06:02Z","timestamp":1594641962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Epidemiology, species distribution, and predictive factors for mortality of candidemia in adult surgical patients"],"prefix":"10.1186","volume":"20","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingpeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,13]]},"reference":[{"key":"5238_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1086\/421946","volume":"39","author":"H Wisplinghoff","year":"2004","unstructured":"Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309\u201317.","journal-title":"Clin Infect Dis"},{"key":"5238_CR2","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","volume":"370","author":"SS Magill","year":"2014","unstructured":"Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370:1198\u2013208.","journal-title":"N Engl J Med"},{"key":"5238_CR3","first-page":"360","volume":"59","author":"I Hassan","year":"2009","unstructured":"Hassan I, Powell G, Sidhu M, Hart WM, Denning DW. Excess mortality, length of stay and cost attributable to candidaemia. J Inf Secur. 2009;59:360\u20135.","journal-title":"J Inf Secur"},{"key":"5238_CR4","doi-asserted-by":"publisher","first-page":"O245","DOI":"10.1111\/1469-0691.12380","volume":"20","author":"M Puig-Asensio","year":"2014","unstructured":"Puig-Asensio M, Padilla B, Garnacho-Montero J, Zaragoza O, Aguado JM, Zaragoza R, et al. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin Microbiol Infect. 2014;20:O245\u201354.","journal-title":"Clin Microbiol Infect"},{"key":"5238_CR5","doi-asserted-by":"publisher","first-page":"e759","DOI":"10.1016\/j.ijid.2011.06.006","volume":"15","author":"I Das","year":"2011","unstructured":"Das I, Nightingale P, Patel M, Jumaa P. Epidemiology, clinical characteristics, and outcome of candidemia: experience in a tertiary referral center in the UK. Int J Infect Dis. 2011;15:e759\u201363.","journal-title":"Int J Infect Dis"},{"key":"5238_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1086\/321811","volume":"33","author":"HM Blumberg","year":"2001","unstructured":"Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of mycosis survey. Clin Infect Dis. 2001;33:177\u201386.","journal-title":"Clin Infect Dis"},{"key":"5238_CR7","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.mycmed.2017.02.007","volume":"27","author":"A Vaezi","year":"2017","unstructured":"Vaezi A, Fakhim H, Khodavaisy S, Alizadeh A, Nazeri M, Soleimani A, et al. Epidemiological and mycological characteristics of candidemia in Iran: a systematic review and meta-analysis. J Mycol Med. 2017;27:146\u201352.","journal-title":"J Mycol Med"},{"key":"5238_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.diagmicrobio.2012.02.001","volume":"73","author":"D Diekema","year":"2012","unstructured":"Diekema D, Arbefeville S, Boyken L, Kroeger J, Pfaller M. The changing epidemiology of healthcare-associated candidemia over three decades. Diagn Microbiol Infect Dis. 2012;73:45\u20138.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"5238_CR9","first-page":"B4698","volume":"60","author":"MC Arendrup","year":"2013","unstructured":"Arendrup MC. Candida and candidaemia. Susceptibility and epidemiology Dan Med J. 2013;60:B4698.","journal-title":"Susceptibility and epidemiology Dan Med J"},{"key":"5238_CR10","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1007\/s00134-003-2002-x","volume":"29","author":"PE Charles","year":"2003","unstructured":"Charles PE, Doise JM, Quenot JP, Aube H, Dalle F, Chavanet P, et al. Candidemia in critically ill patients: difference of outcome between medical and surgical patients. Intensive Care Med. 2003;29:2162\u20139.","journal-title":"Intensive Care Med"},{"key":"5238_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185339","volume":"12","author":"A Vena","year":"2017","unstructured":"Vena A, Bouza E, Valerio M, Padilla B, Pano-Pardo JR, Fernandez-Ruiz M, et al. Candidemia in non-ICU surgical wards: comparison with medical wards. PLoS One. 2017;12:e0185339.","journal-title":"PLoS One"},{"key":"5238_CR12","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/myc.12988","volume":"62","author":"E Orsetti","year":"2019","unstructured":"Orsetti E, Brescini L, Mazzanti S, Trave F, Morroni G, Masucci A, et al. Characterisation of candidemia in patients with recent surgery: a 7-year experience. Mycoses. 2019;62:1056\u201363.","journal-title":"Mycoses."},{"key":"5238_CR13","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268819001638","volume":"147","author":"W Zhang","year":"2019","unstructured":"Zhang W, Song X, Wu H, Zheng R. Epidemiology, risk factors and outcomes of Candida albicans vs. non-albicans candidaemia in adult patients in Northeast China. Epidemiol Infect. 2019;147:e277.","journal-title":"Epidemiol Infect"},{"key":"5238_CR14","unstructured":"CLSI. Performance Standards for Antifungal Susceptibility Testing of Yeasts. 1st Edition. CLSI supplement M60. Wayne: Clinical and Laboratory Standards Institute. [https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m60\/] Accessed 12 June 2019."},{"key":"5238_CR15","unstructured":"EUCAST. European Committee on Antimicrobial Susceptibility Testing Antifungal Agents Breakpoint tables for interpretation of MICs, Version 9.0, valid from 2018-02-12. [http:\/\/www.eucast.org\/clinical_breakpoints\/] Accessed 12 June 2019."},{"key":"5238_CR16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s00134-007-0865-y","volume":"34","author":"ME Bougnoux","year":"2008","unstructured":"Bougnoux ME, Kac G, Aegerter P, d'Enfert C, Fagon JY, CandiRea SG. Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med. 2008;34:292\u20139.","journal-title":"Intensive Care Med"},{"issue":"Suppl 6","key":"5238_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/1469-0691.12539","volume":"20","author":"J Guinea","year":"2014","unstructured":"Guinea J. Global trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect. 2014;20(Suppl 6):5\u201310.","journal-title":"Clin Microbiol Infect"},{"key":"5238_CR18","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s00134-017-4743-y","volume":"43","author":"O Lortholary","year":"2017","unstructured":"Lortholary O, Renaudat C, Sitbon K, Desnos-Ollivier M, Bretagne S, Dromer F, et al. The risk and clinical outcome of candidemia depending on underlying malignancy. Intensive Care Med. 2017;43:652\u201362.","journal-title":"Intensive Care Med"},{"key":"5238_CR19","doi-asserted-by":"crossref","unstructured":"Puig-Asensio M, Ruiz-Camps I, Fernandez-Ruiz M, Aguado JM, Munoz P, Valerio M, et al. Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain. Clin Microbiol Infect. 2015;21:491 e1\u201310.","DOI":"10.1016\/j.cmi.2014.12.027"},{"key":"5238_CR20","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/myc.12013","volume":"56","author":"MD Bergamasco","year":"2013","unstructured":"Bergamasco MD, Garnica M, Colombo AL, Nucci M. Epidemiology of candidemia in patients with hematologic malignancies and solid tumours in Brazil. Mycoses. 2013;56:256\u201363.","journal-title":"Mycoses."},{"key":"5238_CR21","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1128\/JCM.44.5.1681-1685.2006","volume":"44","author":"B Almirante","year":"2006","unstructured":"Almirante B, Rodriguez D, Cuenca-Estrella M, Almela M, Sanchez F, Ayats J, et al. Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol. 2006;44:1681\u20135.","journal-title":"J Clin Microbiol"},{"key":"5238_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0732-8893(98)00006-6","volume":"30","author":"AS Levin","year":"1998","unstructured":"Levin AS, Costa SF, Mussi NS, Basso M, Sinto SI, Machado C, et al. Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheters and the hands of healthcare workers. Diagn Microbiol Infect Dis. 1998;30:243\u20139.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"5238_CR23","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1128\/CMR.00013-08","volume":"21","author":"D Trofa","year":"2008","unstructured":"Trofa D, Gacser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev. 2008;21:606\u201325.","journal-title":"Clin Microbiol Rev"},{"key":"5238_CR24","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1128\/JCM.01998-13","volume":"51","author":"M Bassetti","year":"2013","unstructured":"Bassetti M, Merelli M, Righi E, Diaz-Martin A, Rosello EM, Luzzati R, et al. Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain. J Clin Microbiol. 2013;51:4167\u201372.","journal-title":"J Clin Microbiol"},{"key":"5238_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.diagmicrobio.2006.11.009","volume":"58","author":"M Nucci","year":"2007","unstructured":"Nucci M, Colombo AL. Candidemia due to Candida tropicalis: clinical, epidemiologic, and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals. Diagn Microbiol Infect Dis. 2007;58:77\u201382.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"5238_CR26","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1128\/JCM.02363-09","volume":"48","author":"GM Lyon","year":"2010","unstructured":"Lyon GM, Karatela S, Sunay S, Adiri Y. Antifungal susceptibility testing of Candida isolates from the Candida surveillance study. J Clin Microbiol. 2010;48:1270\u20135.","journal-title":"J Clin Microbiol"},{"key":"5238_CR27","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.2217\/fmb-2016-0099","volume":"11","author":"H Wang","year":"2016","unstructured":"Wang H, Xu YC, Hsueh PR. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region. Future Microbiol. 2016;11:1461\u201377.","journal-title":"Future Microbiol"},{"key":"5238_CR28","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ1194","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the Management of Candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:e1\u201350.","journal-title":"Clin Infect Dis"},{"key":"5238_CR29","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/00000658-200104000-00010","volume":"233","author":"RK Pelz","year":"2001","unstructured":"Pelz RK, Hendrix CW, Swoboda SM, Diener-West M, Merz WG, Hammond J, et al. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg. 2001;233:542\u20138.","journal-title":"Ann Surg"},{"key":"5238_CR30","doi-asserted-by":"crossref","unstructured":"Zilberberg M, Yu HT, Chaudhari P, Emons MF, Khandelwal N, Shorr AF. Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study. Critical care [London, England). 2014;18:590.","DOI":"10.1186\/s13054-014-0590-1"},{"issue":"Suppl 7","key":"5238_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/1469-0691.12039","volume":"18","author":"OA Cornely","year":"2012","unstructured":"Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect. 2012;18(Suppl 7):19\u201337.","journal-title":"Clin Microbiol Infect"},{"key":"5238_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003834","volume":"95","author":"TY Wang","year":"2016","unstructured":"Wang TY, Hung CY, Shie SS, Chou PC, Kuo CH, Chung FT, et al. The clinical outcomes and predictive factors for in-hospital mortality in non-neutropenic patients with candidemia. Medicine. 2016;95:e3834.","journal-title":"Medicine."},{"key":"5238_CR33","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s15010-016-0924-9","volume":"44","author":"R Luzzati","year":"2016","unstructured":"Luzzati R, Merelli M, Ansaldi F, Rosin C, Azzini A, Cavinato S, et al. Nosocomial candidemia in patients admitted to medicine wards compared to other wards: a multicentre study. Infection. 2016;44:747\u201355.","journal-title":"Infection."},{"key":"5238_CR34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ijid.2018.08.010","volume":"76","author":"KR Lausch","year":"2018","unstructured":"Lausch KR, Sogaard M, Rosenvinge FS, Johansen HK, Boysen T, Roder B, et al. High incidence of candidaemia in a nationwide cohort: underlying diseases, risk factors and mortality. Int J Infect Dis. 2018;76:58\u201363.","journal-title":"Int J Infect Dis"},{"key":"5238_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijid.2016.09.018","volume":"52","author":"N Eliakim-Raz","year":"2016","unstructured":"Eliakim-Raz N, Babaoff R, Yahav D, Yanai S, Shaked H, Bishara J. Epidemiology, microbiology, clinical characteristics, and outcomes of candidemia in internal medicine wards-a retrospective study. Int J Infect Dis. 2016;52:49\u201354.","journal-title":"Int J Infect Dis"},{"key":"5238_CR36","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s10096-018-3304-9","volume":"37","author":"X Jia","year":"2018","unstructured":"Jia X, Li C, Cao J, Wu X, Zhang L. Clinical characteristics and predictors of mortality in patients with candidemia: a six-year retrospective study. Eur J Clin Microbiol Infect Dis. 2018;37:1717\u201324.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5238_CR37","first-page":"153","volume":"35","author":"H Wang","year":"2014","unstructured":"Wang H, Wu DW, Han H, Yue JF, Zhang F, Shan TC, et al. Antibiotics exposure, risk factors, and outcomes with Candida albicans and non-Candida albicans candidemia. Results from a multi-center study. Saudi Med J. 2014;35:153\u20138.","journal-title":"Saudi Med J"},{"key":"5238_CR38","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jhin.2005.02.009","volume":"61","author":"M Weinberger","year":"2005","unstructured":"Weinberger M, Leibovici L, Perez S, Samra Z, Ostfeld I, Levi I, et al. Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality. The Journal of hospital infection. 2005;61:146\u201354.","journal-title":"The Journal of hospital infection"},{"key":"5238_CR39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1053\/jhin.2001.1151","volume":"50","author":"V Krcmery","year":"2002","unstructured":"Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. The Journal of hospital infection. 2002;50:243\u201360.","journal-title":"The Journal of hospital infection."},{"key":"5238_CR40","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.3390\/ijms20143494","volume":"20","author":"F Vardon-Bounes","year":"2019","unstructured":"Vardon-Bounes F, Ruiz S, Gratacap MP, Garcia C, Payrastre B, Minville V. Platelets are critical key players in Sepsis. Int J Mol Sci. 2019;20:3494.","journal-title":"Int J Mol Sci"},{"key":"5238_CR41","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.it.2019.08.004","volume":"40","author":"L Nicolai","year":"2019","unstructured":"Nicolai L, Gaertner F, Massberg S. Platelets in host defense: experimental and clinical insights. Trends Immunol. 2019;40:922\u201338.","journal-title":"Trends Immunol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05238-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05238-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05238-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T23:14:14Z","timestamp":1626131654000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05238-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,13]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5238"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05238-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,13]]},"assertion":[{"value":"25 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Medical Ethics Committee in Shengjing Hospital of China Medical University (reference number 2019PS636K). Informed consent was not obtained from individual patients because the data were collected retrospectively.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests. The authors alone are responsible for the content and the writing of the paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"506"}}